As expected, TNFα treatment greatly increased MCP-1 secretion, which is consistent with the idea that TNFα is a strong proinflammatory inducer of MCP-1 in obesity. The gene discussed is CCL2; the disease is obesity due to melanocortin 4 receptor deficiency.